Base to Base biotech podcast 6: Persica Pharmaceuticals and Caszyme

This week on the podcast, we have a conversation with Steve Ruston, CEO of Persica Pharmaceuticals, about treating chronic low back pain, and with Monika Paulė, CEO and co-founder of Caszyme.

Interview time stamps:

Times: 01:40 Caszyme

16:04 Persica Pharmaceuticals

Persica Pharmaceuticals

Persica is developing a potentially transformative non-opioid treatment for chronic low back pain (cLBP) with some interesting phase 1b data.

Chronic low back pain is a problem that affects millions of people, many of whom aren’t helped by existing treatments. Persica’s drug aims to be the first approved pharmaceutical to target cLBP as ...